CD274 and non-small cell lung carcinoma: Furthermore, PD-L1 positivity was correlated with copy gain of CD274 (PD-L1) and PDCD1LG2 (PD-L2) in American nonsquamous NSCLC patients in a study using clone E1L3N with the cutoff at ≥1% [12].